LUCENT

We're #hiring a new Senior Account Manager/ Account Director in United Kingdom. Apply today or share this post with your network.

Did you miss our article on the challenges in bridging the vision for Field Medical with reality? Field Medical associates have the skills to convey scientific data with impact - building trusted, high-value and long-lasting scientific partnerships with healthcare professionals. But there are complexities to this. Read our article to explore this further: https://lnkd.in/e22RcmtW #FieldMedical #MSL #MedicalAffairs

I'd love to see the success rates of biopharma development assets compared to other industries - e.g. Software/Hardware products. We lose track in our industry of the insanely high risks we run with every development project. We also forget that when things do fail (and they do, much more often than they succeed) that almost all the work done up until that point goes in the trash - which isn't the case in any other industry.

The way medical information requests are handled is often inefficient and cumbersome. Response letters to HCP queries require an experienced, trained professional to collate, analyse and convey actionable information that is easily comprehendable and applied in practice. HCP requests and questions can be incredibly complicated to respond to and usually a vast amount of time and resource is poured into responses. LUCENT’s Medical Information Team can alleviate the time and resource your organisation needs to commit to HCP responses. Our MI Team has the expertise to produce Standard and Customer Response Letters, for country affiliates or at a regional level. We can also support with wider Medical Information activities such as internal training and Q&A documents. By using LUCENT’s Medical Information Team, you can be confident in the acumen of your responses, that are scientifically balanced, evidence based, without commercial bias and ensuring transparency. What is stopping you from contacting us today? #MedicalAffairs #MedicalFunction #MedicalInformation #MedicalExcellence https://lnkd.in/eH_jbEME

High-quality medical - marketing collaboration is essential for any successful new medicine launch. On the whole, the two departments work well together. However, we have seen issues quickly escalate, causing long lasting damage to relationships and to the launch. We've looked in more detail at where issues originally stem from and have consolidated them down into three underlying themes. Take a look in our most recent article... #MedicalAffairs #MedicalMarketing #Pharmaceuticals #BioPharma

Over the last ten years, the success rate of clinical trials has decreased, from a high of 24.5% in 2015 across Phase 1, 2 and 3. The chart below shows the chance of success of reaching market for drugs in each phase of clinical trials over the past ten years. Maximising on the innovative ecosystem, ensuring successful investment and optimising clinical trial methodology to shorten trial duration or reduce the white space between phases is essential to successful outcomes in clinical development. Success rates appear to be improving based on data from 2022 and 2023. Read the latest from IQVIA in their Global Trends in R&D 2024 report: https://lnkd.in/eNHKxEgv #ClinicalDevelopment #MedicalAffairs #ClinicalTrials

The global biopharma industry is witnessing groundbreaking advancements in therapies and technologies that have the potential to transform lives. However, the industry's resilience has declined since 2021 due to various external factors. To ensure the successful launch of these innovative treatments, it is crucial to assess both your business's resilience and the resilience of each target country against these five key factors. Adapted from Cytiva's 2023 Global Biopharma Resilience Index Report. #BioPharma #MedicalAffairs

Are you confident in the success of your product launch? Have you considered your customers' needs? Feedback is essential for planning, decision making and improving confidence. Scientific advisory boards are an effective way of bringing people together to collaborate, exchange information, and obtain valuable feedback. LUCENT can quickly and effectively validate and enhance your medical plans. Contact us today to explore how we can help: https://lnkd.in/eC_N_u3E #MedicalAffairs #CustomerFocus #BioPharma #Pharmaceuticals #AdvisoryBoard

To launch in Europe, you need to know the landscape specifics and have a tailored medical strategy that tightly aligns with the commercial strategy for each country. Let LUCENT take care of your EU go-to-market medical and omnichannel strategy by installing expertise and confidence into your plans. Read our insights on the EU digital healthcare landscape here: https://lnkd.in/eTyWX7xC #EuropeanLaunch #Pharmaceuticals #Biotech #Medicalaffairs #MedicalOmnichannel